Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Nanomedicine 2013

Erem Bilensoy's Biography



Erem Bilensoy, Associate Professor, Hacettepe University

Erem Bilensoy graduated from Hacettepe University Faculty of Pharmacy in 1992. She received her M.Sc. degree on Pharmaceutical Technology with her thesis on the in vitro/in vivo evaluation of recombinant human Granulocyte Macrophage-Colony Stimulating Factor loaded niosome, emulsion and liquid crystal formulations for wound healing in the same university. She obtained her double Ph.D. degree with a co-tutelle thesis between Université Paris-Sud, France and Hacettepe University in 2002 on the evaluation of amphiphilic ß-cyclodextrins modified on the primary face as novel excipients in the preparation of nanospheres and nanocapsules. Erem Bilensoy worked as assistant professor between 2005-2007 and received her Associate Professor title in 2007. She is currently continuing her research work at the Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University.
Dr. Bilensoy has served as BA/BE Evaluation Commission member between 2007-2012 and is the writer of 45 scientific articles, 8 international book chapters. She has given several invited lectures, oral and poster presentations receiving more than 350 citations with a H-index of 15.
She recently edited a book entitled “Cyclodextrins in Pharmaceutics, Cosmetics and Biomedicine: Current and Future Industrial Applications” published in May 2011 by John Wiley&Sons.
Dr. Bilensoy was awarded Hacettepe University Scientific Promotion Award for Health Sciences, METU Parlar Foundation Scientific Promotion Award and Turkish Urooncology Society Cancer Research Award in 2009 and Teknovasyon Pfizer Health Sciences Project Award in 2011 for her work on bladder cancer therapy with cationic nanoparticulate drug delivery systems.
She is serving as founder member and scientific secretary for EUFEPS Network on Nanomedicine since 2010 and Executive Committee Member for European Cyclodextrin Society since 2009. She is Editorial Board Member of Recent Patents in Drug Delivery and Formulation. She has been elected chair of the upcoming 3rd European Conference on Cyclodextrins to be held in October 2013 in Turkey.
Her current research interests include nanoparticles in cancer therapy, cationic nanoparticles, cyclodextrin-based drug delivery and bioavailability/bioequivalence.
She is also serving as Vice Dean and Student Coordinator of Faculty of Pharmacy at Hacettepe University since January 2010. Erem Bilensoy is married and is the mother of Deniz Bilensoy aged 9.

Erem Bilensoy Image

Cationic Nanoparticles for Cancer Chemotherapy

Friday, 12 April 2013 at 11:45

Add to Calendar ▼2013-04-12 11:45:002013-04-12 12:45:00Europe/LondonCationic Nanoparticles for Cancer ChemotherapyNanomedicine 2013 in Barcelona, SpainBarcelona, SpainSELECTBIOenquiries@selectbiosciences.com

Nanoparticles are promising delivery systems for the local or systemic application of anticancer drugs and active molecules with bioavailability problems. As a result of their favourable size distribution, nanoparticles can be targeted to tumor tissues via the Enhanced Permeation and Retention (EPR) Effect. In this sense, active targeting of anticancer drugs may also be achieved by surface modification of the nanoparticles. Positive surface charge affects the intracellular drug delivery and cellular uptake of nanoparticles due to improved interaction with biological membranes.  Potential of cationic nanoparticles will be discussed in view of in vitro, cell culture and in vivo data.


Add to Calendar ▼2013-04-11 00:00:002013-04-12 00:00:00Europe/LondonNanomedicine 2013Nanomedicine 2013 in Barcelona, SpainBarcelona, SpainSELECTBIOenquiries@selectbiosciences.com